APO-RIVASTIGMINE rivastigmine (as hydrogen tartrate) 3mg capsule bottle

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

ダウンロード 公開評価報告書 (PAR)
29-11-2017

有効成分:

rivastigmine hydrogen tartrate, Quantity: 4.8 mg

から入手可能:

Arrotex Pharmaceuticals Pty Ltd

INN(国際名):

rivastigmine hydrogen tartrate

医薬品形態:

Capsule

構図:

Excipient Ingredients: titanium dioxide; microcrystalline cellulose; Gelatin; maize starch; iron oxide yellow; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; Shellac; strong ammonia solution; iron oxide black; potassium hydroxide

投与経路:

Oral

パッケージ内のユニット:

56, 500, 100

処方タイプ:

(S4) Prescription Only Medicine

適応症:

Rivastigmine is indicated for the treatment of patients with mild to moderately severe dementia of the Alzheimer's type

製品概要:

Visual Identification: Hard gelatine calsule with orange, opaque body and orange opaque cap. Imprinted "APO R3" in black ink, white to off white fill.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 12 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

認証ステータス:

Registered

承認日:

2010-07-27